Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew F Wack

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Spine|September 27, 2016
Propionibacterium acnes, Coagulase-Negative Staphylococcus, and the "Biofilm-like" Intervertebral DiscMichael F Coscia, Gerald A Denys, Matthew F Wack
Diagnostic Microbiology and Infectious Disease|June 29, 2002
Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutationMichael B Kays, Matthew F Wack, David W Smith, et al.
Vascular and Endovascular Surgery|February 5, 2009
Case study: chronic femoropopliteal prosthetic graft infection with exposed graftRobert A McCready, M Ann Bryant, Janet Divelbiss, et al.
Pharmacotherapy|May 28, 2008
Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patientsS Christian Cheatham, Michael B Kays, David W Smith, et al.
International Journal of Antimicrobial Agents|September 4, 2009
Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patientsKatherine M Shea, S Christian Cheatham, Matthew F Wack, et al.
The Annals of Pharmacotherapy|October 8, 2009
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patientsKatherine M Shea, S Christian Cheatham, David W Smith, et al.
Mycoses|August 23, 2006
Delayed ABLC prophylaxis after allogeneic stem-cell transplantationJan Jansen, Luke P Akard, Matthew F Wack, et al.
Pharmacotherapy|January 27, 2007
Selection of a gyrA mutation and treatment failure with gatifloxacin in a patient with Streptococcus pneumoniae with a preexisting parC mutationMichael B Kays, George G Zhanel, Megan A Reimann, et al.
International Journal of Antimicrobial Agents|November 16, 2010
Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patientsS Christian Cheatham, Katherine M Shea, Daniel P Healy, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Spine|September 27, 2016
Propionibacterium acnes, Coagulase-Negative Staphylococcus, and the "Biofilm-like" Intervertebral DiscMichael F Coscia, Gerald A Denys, Matthew F Wack
Diagnostic Microbiology and Infectious Disease|June 29, 2002
Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutationMichael B Kays, Matthew F Wack, David W Smith, et al.
Vascular and Endovascular Surgery|February 5, 2009
Case study: chronic femoropopliteal prosthetic graft infection with exposed graftRobert A McCready, M Ann Bryant, Janet Divelbiss, et al.
Pharmacotherapy|May 28, 2008
Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patientsS Christian Cheatham, Michael B Kays, David W Smith, et al.
International Journal of Antimicrobial Agents|September 4, 2009
Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patientsKatherine M Shea, S Christian Cheatham, Matthew F Wack, et al.
The Annals of Pharmacotherapy|October 8, 2009
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patientsKatherine M Shea, S Christian Cheatham, David W Smith, et al.
Mycoses|August 23, 2006
Delayed ABLC prophylaxis after allogeneic stem-cell transplantationJan Jansen, Luke P Akard, Matthew F Wack, et al.
Pharmacotherapy|January 27, 2007
Selection of a gyrA mutation and treatment failure with gatifloxacin in a patient with Streptococcus pneumoniae with a preexisting parC mutationMichael B Kays, George G Zhanel, Megan A Reimann, et al.
International Journal of Antimicrobial Agents|November 16, 2010
Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patientsS Christian Cheatham, Katherine M Shea, Daniel P Healy, et al.
Pageof 1